Temporal Trends in and Factors Associated With Bleeding Complications Among Patients Undergoing Percutaneous Coronary Intervention
- 1 May 2012
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 59 (21), 1861-1869
- https://doi.org/10.1016/j.jacc.2011.12.045
Abstract
No abstract availableKeywords
Funding Information
- The Medicines Company
- Bristol-Myers Squibb/sanofi-aventis
- Merck
- Eli Lilly
- Johnson and Johnson
- American Heart Association
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline
- KAI Pharmaceuticals
- Novartis
- Sanofi-Aventis
- Schering-Plough Corporation
- Orexigen
This publication has 28 references indexed in Scilit:
- Changes in glycoprotein IIb/IIIa inhibitor excess dosing with site-specific safety feedback in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines (CRUSADE) initiativeAmerican Heart Journal, 2010
- Impact of Femoral Vascular Closure Devices and Antithrombotic Therapy on Access Site Bleeding in Acute Coronary SyndromesCirculation: Cardiovascular Interventions, 2010
- Bleeding in Patients Undergoing Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2009
- Fluoroscopy‐Guided Femoral Artery Puncture Reduces the Risk of PCI‐Related Vascular ComplicationsJournal of Interventional Cardiology, 2008
- Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction?Circulation, 2007
- Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromesEuropean Heart Journal, 2007
- A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devicesAmerican Heart Journal, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCell Metabolism, 2006
- Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study)The American Journal of Cardiology, 2004
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001